Efficacy and Safety of Empagliflozin Versus Sitagliptin in Patients With Type 2 Diabetes
Status:
Withdrawn
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess safety and efficacy of empagliflozin compared to
sitagliptin in patients with type 2 diabetes mellitus who are treatment-naive or on treatment
with metformin and have insufficient glycaemic control. The study will assess non-inferiority
of empagliflozin to sitagliptin with regards to HbA1c.